The experience of Mitomycin-C given as a once weekly intraveneous injection for carcinoma of gastroenteric and breast origin with review of recent literature is given. Limited activity was seen in gastric and colorectal carcinoma. Similar to the experience of others, hematological toxicity (thrombocytopenia and/or leukopenia) was the dose-limiting toxicity encountered. Although the once weekly schedule was not directly compared with other reported schedules, it seems clear there was no reduction of significant and dose-limiting hematological toxicity nor enhancement of therapeutic efficacy.
Hexamethylmelamine (HMM) was administered by mouth to 115 patients; 108 were eligible for the study and were evaluated for toxicity, while 82 completed one 21‐day course and were evaluated for response. Responses exceeding 50% in tumor reduction were observed in 1 of 41 evaluable patients (2%) with lung carcinoma and in 4 of 10 with squamous carcinoma of the cervix. HMM was also given in combination with NSC‐45388 (ICDT) to 30 patients; 27 were eligible for the study and were evaluated for toxicity, while 25 completed one 21‐day course and were evaluated for response. Responses exceeding 50% were obtained in 2 of 16 evaluable patients with melanoma and in none of 5 patients with lung carcinoma. Toxic effects of therapy included nausea and vomiting, leukopenia, thrombocytopenia, anemia, and both central and peripheral nervous system manifestations. Further study of HMM in carcinoma of the cervix would be of interest. Further trial of combined HMM and ICDT was abandoned because of the nausea encountered.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.